Discontinuation report ACT VENLAFAXINE XR

Last updated on 2018-10-22 History
Report ID 65292
Drug Identification Number 02304325
Brand name ACT VENLAFAXINE XR
Common or Proper name VENLAFAXINE XR
Company Name TEVA CANADA LIMITED
Active Ingredient(s) VENLAFAXINE
Strength(s) 75.0MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 500
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-06-30
Remaining supply date 2018-08-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Transitioned. TEVA available
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2018-10-22 French Compare
v1 2018-10-22 English Compare